AEON Biopharma, Inc. (AEON) vs Pluri Inc. (PLUR)

AEON Biopharma, Inc. and Pluri Inc. are both Biotechnology companies. AEON Biopharma, Inc. and Pluri Inc. are of similar size ($13.0M and $12.7M). AEON Biopharma, Inc. has the higher net margin (0.00% vs −2,344.6%) and the higher return on invested capital (0.00% vs −526.9%). Across the 12 metrics below, AEON Biopharma, Inc. leads on 8 and Pluri Inc. on 4.

Valuation

Metric AEON PLUR Biotechnology median
P/E n/m n/m 7.88
P/S n/m 10.07 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 30.14 10.73
Earnings yield (1,700.00%) (233.33%) (28.84%)
Free cash flow yield (103.87%) (197.46%) (23.03%)

Profitability

Metric AEON PLUR Biotechnology median
Gross margin — 44.59% 65.16%
Operating margin 0.00% (2,454.53%) 0.00%
Net margin 0.00% (2,344.59%) 0.00%
Free cash flow margin 0.00% (1,988.48%) 0.00%
Return on equity 350.00% 260.35% (57.72%)
Return on assets (621.70%) (74.95%) (49.22%)
Return on invested capital 0.00% (526.92%) 0.00%

Growth

Metric AEON PLUR Biotechnology median
Revenue growth (TTM) — (23.95%) 5.64%
EPS growth (last fiscal year) (105.42%) 31.46% —
Revenue growth, 5-year CAGR — 113.32% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AEON PLUR Biotechnology median
Debt to equity 0.00 (1.62) 0.00
Current ratio 0.54 0.27 4.73
Net debt to EBITDA (2.48) (0.83) 0.96

Dividend

Metric AEON PLUR Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric AEON PLUR Biotechnology median
Market cap 12.65m 12.96m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack